Your browser doesn't support javascript.
loading
Conventional, biological disease-modifying anti-rheumatic drugs and Janus kinase inhibitors and varicella zoster virus.
Atzeni, Fabiola; Gozza, Francesco; Riva, Agostino; Alciati, Alessandra; Galloway, James.
Affiliation
  • Atzeni F; Rheumatology Unit, Department of Experimental and Internal Medicine, University of Messina, Messina, Italy.
  • Gozza F; Rheumatology Unit, Department of Experimental and Internal Medicine, University of Messina, Messina, Italy.
  • Riva A; Department of Biomedical and Clinical Sciences "L. Sacco," University of Milan, Milan, Italy.
  • Alciati A; III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy.
  • Galloway J; Department of Clinical Neurosciences, Villa S. Benedetto Menni, Albese (Como), Italy.
Expert Opin Pharmacother ; 24(6): 679-689, 2023 Apr.
Article in En | MEDLINE | ID: mdl-36946287
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Antirheumatic Agents / Janus Kinase Inhibitors / Herpes Zoster Type of study: Screening_studies Limits: Humans Language: En Journal: Expert Opin Pharmacother Journal subject: FARMACOLOGIA Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Antirheumatic Agents / Janus Kinase Inhibitors / Herpes Zoster Type of study: Screening_studies Limits: Humans Language: En Journal: Expert Opin Pharmacother Journal subject: FARMACOLOGIA Year: 2023 Document type: Article Affiliation country: Country of publication: